carbenoxolone sodium has been researched along with tamoxifen in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Bowman-Gram, TA; Johnson, WD; Kellof, GJ; Lubet, RA; McCormick, DL; Rao, KV; Steele, VE | 1 |
| Kettenmann, H; Oberheim, N; Ransom, BR; Ye, ZC | 1 |
4 other study(ies) available for carbenoxolone sodium and tamoxifen
| Article | Year |
|---|---|
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Exceptional chemopreventive activity of low-dose dehydroepiandrosterone in the rat mammary gland.
Topics: Animals; Anticarcinogenic Agents; Carbenoxolone; Carcinogens; Dehydroepiandrosterone; Diet; Drug Administration Schedule; Female; Mammary Neoplasms, Experimental; Methylnitrosourea; Rats; Rats, Sprague-Dawley; Tamoxifen | 1996 |
Pharmacological "cross-inhibition" of connexin hemichannels and swelling activated anion channels.
Topics: Amino Acids; Analysis of Variance; Angiogenesis Inhibitors; Animals; Animals, Newborn; Astrocytes; Carbenoxolone; Cell Size; Cells, Cultured; Chromatography, High Pressure Liquid; Connexin 43; Glycyrrhetinic Acid; Hippocampus; Hypotonic Solutions; Indans; Ion Channel Gating; Ion Channels; Isoquinolines; Mice; Mice, Knockout; Nitrobenzoates; Rats; Tamoxifen | 2009 |